| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Gyre Pharmaceuticals | $14.41M | $13.7M | $16.86M | $10.84M | $15.19M | $15.33M | $23.82M | $14.14M |
| Gyre | — | — | — | — | — | — | — | $0 |
| All Other Segments | — | — | — | — | — | — | — | $0 |
| Total | $14.41M | $13.7M | $16.86M | $10.84M | $15.19M | $15.33M | $23.82M | $14.14M |